Evidence map›Paper›PMID 36124735›Full record

ArticleThe international journal of neuropsychopharmacology2022

Inhibition of Phosphodiesterase 2 Ameliorates Post-Traumatic Stress-Induced Alcohol Intake Disorder by Regulating cAMP/cGMP Signaling.

Xiaoyu Pan, Ling Chen, Chunyan Shan, Lisha Cai, Yue Wang, Yue Chen, Ming Gu, Kaiping Liu, Pihong Li, Jianchun Pan

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Longevity, enhanced memory, and altered density of dendritic spines in hippocampal CA3 and dentate gyrus after hemizygous deletion of Pde2a in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiaoyu PanDepartment of General Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Ling ChenDepartment of Clinical Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chunyan ShanClinical Research Center, The Affiliated Kangning Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Lisha CaiBrain Institute, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Yue WangDepartment of General Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yue ChenBrain Institute, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Ming GuBrain Institute, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Kaiping LiuBrain Institute, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Pihong LiDepartment of General Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jianchun PanBrain Institute, School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Wenzhou Medical University · CNHangzhou First People's Hospital · CNJinzhou Kangning Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPost-traumatic stress disorder (PTSD) is the prevalent psychiatric disorder that induces alcohol use disorders (AUD) such as abnormal alcohol intake and anxiety. However, little is known about whether phosphodiesterase 2 (PDE2)-cAMP/cGMP signaling is involved in PTSD-induced AUD.

methodsThe present study used single-prolonged stress (SPS) to mimic PTSD that induced increases in ethanol intake and preference (2-bottle choice test) and anxiety-like behavior (elevated-plus maze test and novelty suppressed feeding test). PDE2 inhibitor Bay 60-7550 (Bay) was administered to the mice and protein kinase A (PKA) inhibitor H89 and PKG inhibitor KT5823 were micro-injected into dorsolateral striatum (DLS) and central amygdala (CA) of mice to determine whether the effects of Bay on anxiety-like behavior in SPS mice are brain region dependent.

resultsPDE2 inhibitor Bay rescued SPS-induced decreases in open arm entries and open arm time exposure in elevated-plus maze test and reversed increased latency to feed in the novelty suppressed feeding test. Moreover, SPS-induced ethanol use disorder was reversed by Bay as evidenced by decreased ethanol intake and preference without changing total fluid intake in the SPS mice after treatment with Bay. However, Bay did not change the ethanol metabolism or sucrose or quinine intake and preference. The locomotor activity was not affected after treatment with Bay. Interestingly, microinjection of PKA or PKG inhibitor H89 or KT5823 into DLS prevented the effects of Bay on alcohol intake and preference and cAMP-response element binding proteins phosphorylation and brain derived neurotrophic factor expression in DLS but not on the anxiety-like behavior in SPS mice. Microinjection of these inhibitors into CA prevented Bay-induced anxiolytic-like effects and cAMP-response element binding proteins phosphorylation and brain derived neurotrophic factor levels in CA but did not affect ethanol intake in SPS mice, indicating that the effects of Bay on different behaviors are brain region dependent.

conclusionsThese findings support the hypothesis that PDE2-cAMP/cGMP signaling may differentially mediate PTSD-induced AUD and anxiety-like behavior.

Indexed as

AlcoholismAnti-Anxiety AgentsStress Disorders, Post-TraumaticAlcohol DrinkingAnimalsBrain-Derived Neurotrophic FactorCyclic AMP Response Element-Binding ProteinCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 2Disease Models, AnimalEthanolIsoquinolinesMicePhosphoric Diester HydrolasesSulfonamidesAnti-Anxiety AgentsBrain-Derived Neurotrophic FactorCyclic AMP Response Element-Binding ProteinCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 2EthanolIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamidePhosphoric Diester HydrolasesSulfonamidesalcohol intakecAMP/cGMPPhosphodiesterase 2post-traumatic stresssingle-prolonged stress

Identifiers

PMID36124735
PMCPMC9670747
OpenAlexW4296777451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.